Tag Archives: Healthcare

Hepatitis A Virus Cellular Receptor 2-Pipeline Review, H1 2017

Hepatitis A Virus Cellular Receptor 2Summary
Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2) – Hepatitis A virus cellular receptor 2 (HAVCR2) is a protein encoded by the HAVCR2 gene. It inhibits T-helper type 1 lymphocyte (Th1)-mediated auto- and alloimmune responses and promotes immunological tolerance.

Request for Sample Market Report @http://www.aarkstore.com/sample/521276

Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2) pipeline Target constitutes close to 15 molecules. Out of which approximately 15 molecules are developed by Companies.

The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Scope
– The report provides a snapshot of the global therapeutic landscape for Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2)
– The report reviews Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
– The report reviews key players involved in Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2) targeted therapeutics and enlists all their major and minor projects
– The report assesses Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
– The report summarizes all the dormant and discontinued pipeline projects

Reasons to buy market report
– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand the targeted therapy areas and indications for Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2)
– Identify the use of drugs for target identification and drug repurposing
– Identify potential new clients or partners in the target demographic
– Develop strategic initiatives by understanding the focus areas of leading companies
– Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics

Related Market Research Reports :

Asia-Pacific Ebola Virus Vaccine Market Report 2017

Global Zika Virus Market Research Report 2017

Autoimmune Hepatitis Global Clinical Trials Review, H1, 2017

About Aarkstore:

Aarkstore Enterprise is among global marketing research companies involved in selling market reports across different industries and countries. We help serve thousands of clients annually with syndicated, custom market research and consulting. Collaborating with renowned market research partners, we have continued to etch our presence as an established as channel sales partner of market research intelligence on various frontiers. Clients from all sectors, including public, private, and commercial are endowed with best data modelling and processing structures with custom reports.

For further details, please Contact Us

Advertisements

Lipid Testing POC/Point-of-Care Market: Future Horizons and Growth Strategies-2017

Lipid TestingThis new 340-page report contains 36 tables, and provides a comprehensive analysis of the POC lipid testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC lipid testing market.

Request for Sample Market Report @http://www.aarkstore.com/sample/435063

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation Analysis

– Review of three POC market segments, including their dynamics, trends, structure,
size, growth and major suppliers.

– Five-year test volume and reagent sales forecasts for lipid tests
by market segment:

– Physician Offices/Group Practices
– Emergency Rooms
– Ambulatory Care Centers

Competitive Assessments

– Assessments of major POC suppliers and emerging market entrants,
including their sales, product portfolios, marketing tactics, joint ventures,
and new products in R&D.

Strategic Recommendations

– Specific opportunities for new instruments and reagent systems with potentially
significant market appeal during the next five years.
– Design criteria for POC testing products.
– Alternative business expansion strategies.
– Potential market entry barriers and risks.

Related Market Research Reports:

Biosense Webster Inc – Product Pipeline Analysis, 2017 Update

Medinol Ltd – Product Pipeline Analysis, 2017 Update

Asuragen Inc – Product Pipeline Analysis, 2017 Update

About Aarkstore:

Aarkstore Enterprise is among global marketing research companies involved in selling market reports across different industries and countries. We help serve thousands of clients annually with syndicated, custom market research and consulting. Collaborating with renowned market research partners, we have continued to etch our presence as an established as channel sales partner of market research intelligence on various frontiers. Clients from all sectors, including public, private, and commercial are endowed with best data modelling and processing structures with custom reports.

For further details, please Contact Us

IoT Healthcare Market

IoT HealthcareDescription

The global Internet of Things (IoT) Healthcare market is expected to grow rapidly during the forecast period 2017 to 2025. In the IoT Healthcare market report, the market is segmented based on component, technology, application, and region. The internet of things (IoT) has widespread applications in healthcare domain. Smart sensors, medical device integration along with remote monitoring are some the prime applications of IoT. The application of IoT in healthcare is one of the major revolutionary steps towards healthcare treatment through remote patient monitoring and simplifying access to real-time patient data than conventional paper-based techniques. The impending demand and growing consciousness towards better diagnostics and targeted therapeutic tools are acting as a driving factor for the market globally.

Request for Sample Market Report @http://www.aarkstore.com/sample/483932

Market Drivers

1- Rising demand for advanced solutions for easy monitoring.
2- Use of IoT solutions also reduces the overall operational cost.
3- Growing concern for data security and patient monitoring in a proficient way

Market Segmentation

1- In terms of component, the market has been segmented as system and software, services and hardware.
2- In terms of technology, the market has been segmented into Bluetooth low energy (BLE), Wi-Fi, zigbee, near field communication (NFC), cellular and others.
3- In terms of application, the market has been divided into clinical operations and workflow management, telemedicine, inpatient monitoring, connected imaging, medication management and others.
4- The geographical segmentation for the global IoT healthcare market includes North America, Asia Pacific, Europe, Middle East & Africa (MEA) and Latin America.

Leading Players

Honeywell Life Care Solutions (The U.S.),
Koninklijke Philips N.V. (The Netherlands),
Medtronic PLC (Ireland),
Cisco Systems, Inc. (The U.S.),
GE Healthcare (The U.K.),
Stanley Healthcare (The U.S.),
International Business Machines Corporation (IBM) (The U.S.),

Market Research Reports:

Global Tamoxifen Citrate Market Professional Survey Report 2017

Global Rotary Blower Market Professional Survey Report 2017

About Aarkstore:

Aarkstore Enterprise is among global marketing research companies involved in selling market reports across different industries and countries. We help serve thousands of clients annually with syndicated, custom market research and consulting. Collaborating with renowned market research partners, we have continued to etch our presence as an established as channel sales partner of market research intelligence on various frontiers. Clients from all sectors, including public, private, and commercial are endowed with best data modelling and processing structures with custom reports.

For further details, please Contact Us

Future opportunities in the biobetter space

BiobettersStrategies for success in the biobetter market

How can you successfully position biobetter products in the increasingly crowded branded biologic/biosimilar space?
With the prospect of improving patient adherence, meeting unmet clinical need and increasing revenues, investment in the biobetter pipeline has grown rapidly. Yet biobetter products need to bring some serious clinical and cost saving advantages if they are to get stakeholder support and make a return on investment. Success depends on navigating an undefined regulatory pathway, avoiding IP minefields and ultimately persuading stakeholders that the benefits are worth the cost.

Request for Sample Market Report @http://www.aarkstore.com/sample/452802

Report Overview
In The Future of Biobetters, senior industry experts from leading pharma companies and organisations identify the challenges facing this emerging sector and provide practical and actionable insights for achieving commercial success.

Report Features
Unique insights from US and EU experts in companies such as Takeda, Eisai and MedImmune
Table showing the technologies that can be applied in biobetter development
Graph illustrating EU5+US sales of key biologics scheduled to lose patent protection in 2015-2020
Chart demonstrating how biobetter development requires more analytical capabilities versus originator biologic development
Case Study: Developing a biobetter before an originators patent expiry: lessons from Roche
Case Study: Pulling potential biobetters out of the freezer: Takeda Oncology using advanced technology to reinvigorate a failed biologic projects

Key Benefits

Identify the advantages of biobetters, the value they present, and their competitive position in the branded biologic/biosimilar market
Examine how biobetters can meet unmet clinical need and improve patient outcomes
Understand the current regulatory situation and how this is impacting biobetter development
Investigate potential intellectual property issues that may challenge the sector
Critically appraise biobetter pricing and identify factors that will deliver optimum returns

Expert Views
Each industry expert has been carefully selected for their practical experience and detailed current knowledge of the biobetter sector.
Durgaprasad Annavajjula serves as the Senior Vice President of Stelis Biopharma in the Bengaluru area of India. He is a biopharma research and development senior leader and scientist, with over 25 years of extensive experience in R&D of biopharmaceuticals
Manfred Kurz is responsible for Global Regulatory Affairs (EU) development at Eisai EMEA, based in the UK. He manages the development and regulatory approval of new anti-cancer medicines
Dr. Matt Cooper is the Business Development & Marketing Director at the National Institute for Health Research (NIHR,) Clinical Research Network (CRN), Coordinating Centre in the UK
Phil Morton, Science Director of Bioprocess Characterisation with Albumedix, in the UK, has over 20 years experience in the biopharmaceutical industry within process and product development
Dr. T. Shantha Raju currently holds the position of Senior Director at MedImmune, Maryland, as the Head of Global Bioassay and Quality. His most significant contribution is his research conducted to develop leading cancer therapeutics, such as Rituxan, Herceptin, Avastin, Remicade, and Simponi

 

Who Would Benefit from This Report?

Managers planning biobetter development programmes
HEOR teams building evidence of value for biobetter therapies
MSL teams needing to demonstrate the clinical advantages of biobetters to physicians
Commercial teams negotiating price and formulary position with payers
Regulatory professionals needing to navigate the as yet undefined submission and review pathways
Research managers designing biobetter clinical trials
Corporate managers needing to make strategic investment decisions in the biobetter market

Related Market Research Reports:

Chemotherapy Induced Nausea and Vomiting (CINV) – Market Insights, Epidemiology and Market Forecast- 2023

Global Prosthetic Foot Sales Market Research Report 2017

About Aarkstore:

Aarkstore Enterprise is among global marketing research companies involved in selling market reports across different industries and countries. We help serve thousands of clients annually with syndicated, custom market research and consulting. Collaborating with renowned market research partners, we have continued to etch our presence as an established as channel sales partner of market research intelligence on various frontiers. Clients from all sectors, including public, private, and commercial are endowed with best data modelling and processing structures with custom reports.

For further details, please Contact Us

Insulin Pen Market is likely to reach more than US$ 12 Billion by the year end of 2022.

Insulin PenMarket growth can be attributed to factors such as growing diabetes patient population, high adoption rate, user–friendly design, rising popularity among consumers, help avoid over/under–dosing of insulin, rising market demand for human insulin analogs, government support and technological advancements in the field of insulin pen devices

Insulin Pen Users Insights

China is the leading consumers of insulin pen where XX% of the diabetic population prefer insulin pen. India and Germany have shown its potential to become 2nd and 3rd popular insulin pen users. United States is the fourth leading consumers of insulin pen. Japan and Brazil hold the fifth and sixth leading consumers of insulin pen.

In terms of reusable insulin pen users, China gained its top position as the biggest overall consumer of reusable insulin pen. India and Germany grabbed the #2 and #3 position with XX% and XX% share in 2016 and is likely to maintain its position till the forecast period.

Request for Sample Market Report @ http://www.aarkstore.com/sample/445912

Insulin Pen Market Insights

United States is expected to lead the insulin pen market with a total market share of over 20% by 2022. China and Japan held the #2 and #3 largest market share and is expected to maintain its dominant position during the forecast period.

In terms of Reusable Insulin Pen Market, China and Germany will lead the reusable insulin pen market with more than combined 75% market share by 2022.

In terms of Prefilled Insulin Pen Market, United States accounted for the largest share of the insulin pen market in 2016, followed by Japan and Germany. United States is expected to register the highest CAGR during the forecast period.

Ten Major Markets(10MM) Covered in the Report are as follows

1. United States
2. United Kingdom
3. France
4. Italy
5. Spain
6. Germany
7. Japan
8. China
9. India
10. Brazil

Key Companies Covered in the Report are as follows

1. Novo Nordisk
2. Eli Lilly
3. Sanofi
4. Owen Mumford
5. Ypsomed

Related Market Research Reports:

China Touch Pen Market Research Report 2017

Global Insulin Glargine Market Professional Survey Report 2017

About Aarkstore:

Aarkstore Enterprise is among global marketing research companies involved in selling market reports across different industries and countries. We help serve thousands of clients annually with syndicated, custom market research and consulting. Collaborating with renowned market research partners, we have continued to etch our presence as an established as channel sales partner of market research intelligence on various frontiers. Clients from all sectors, including public, private, and commercial are endowed with best data modelling and processing structures with custom reports.

For further details, please Contact Us

Global Vision Care Market Strategic Assessment and Forecast 2017-2022

Vision CareVision Care Market Report Insights
Vision care products include eyeglasses, contact lenses, intraocular lenses, and other products, which are used to correct visual impairments or prevent blindness. These products, especially eyeglasses, increasingly share their market with functional fashion accessories such as sunglasses, UV protective, and decorative glasses, resulting in the rise of value-added and co-branded products.

Scope of the Report
The report titled Global Vision Care Market Strategic Assessment and Forecast 2017-2022 provides the detailed insights about the global vision care market and its strategic assessment during the period 20172022. The report includes a detailed market analysis for major eye care products sold over the counter (OTC) to consumers.
The report provides the analysis of key segments of the vision care market by product, distribution channels, geography, country, and vendors.

Request for Sample Market Report @  http://www.aarkstore.com/sample/439035

Vision Care Market Market Size and Dynamics
Analysts at Beige Market Intelligence expect that the global vision care market is likely to witness a high growth in its sales during the forecast period. The main driver for the growth is increased incidence of vision impairments and infections, followed by faster replacement and shorter usage cycles. The demand for OTC products is also driven by the rise in innovative and value-added products that no longer just cater to the just functional use but also are emerging to be ideal blends of function and fashion. The global vision care market is likely to grow at a CAGR more than 3% during the forecast period.

Vision Care Market Trends, Drivers, and Challenges
The share of online stores as a distribution channel of the vision care products witnessed an immense growth during the period 20102016. With the increased penetration of internet, the sale distribution of eyeglasses and contact lenses through online stores is expected to increase impressively during the forecast period. The rise of online stores as a distribution channel of vision care products is one of the emerging trends discussed in the report. The other top trends included in the report are transversal usage trends of vision care and fashion accessories and reduced lifecycle of lenses due to pollution and other factors. The computer vision syndrome and prolonged exposure to digital content, increased incidence of eye-disorders corroborated with aging population, and public and private investments to tackle avoidable blindness are among the major growth drivers that are likely to boost the market.

Vision Care Market Key Vendors and Market Share
The market is highly competitive as many local and international players are competing to gain the share of the market. The report profiles all major companies in the global vision care market and also provides the competitive landscape and market shares of key players. It covers the entire market outlook regarding the value chain operating within the market.
Major Vendors
Following are the major vendors that operate in the global vision care market:
Cooper Vision
Essilor
Novartis
Luxottica Group
Johnson & Johnson

Related Market Research Reports:

China Vision Care Products Market Research Report 2017

Global Vision Measuring Systems Advance Noncontact Dimensional Measuring Technologys Sales Market Report 2017

Global Vision Screener Sales Market Report 2017

About Aarkstore:

Aarkstore Enterprise is among global marketing research companies involved in selling market reports across different industries and countries. We help serve thousands of clients annually with syndicated, custom market research and consulting. Collaborating with renowned market research partners, we have continued to etch our presence as an established as channel sales partner of market research intelligence on various frontiers. Clients from all sectors, including public, private, and commercial are endowed with best data modelling and processing structures with custom reports.

For further details, please Contact Us

Seasonal Influenza Vaccine Market is expected to reach more than US$ 4 Billion By 2022

seasonal-influenza-vaccineSeasonal Influenza Vaccine Market is expected to reach more than US$ 4 Billion across the seven major markets (7MM) of the United States, France, Germany, Italy, Spain, United Kingdom and Japan by the year end of 2022.

 

 

Request for Sample Report @http://www.aarkstore.com/sample/290187

Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against seasonal influenza, introduction of quadrivalent influenza vaccines, increase in the size of the elderly population in most countries. The barriers limiting the growth of the influenza market include limited patient awareness regarding the threat of influenza and the importance of influenza vaccinations, high investment and strict regulations act as barriers for new entrants.

 

The United States seasonal influenza vaccine market is the most attractive of those covered in the report. The United States market for seasonal influenza vaccine is expected to grow at a CAGR of XX% and is expected to reach at US$ XXX Million by the end of the forecasted period. United Kingdom will be the second–largest market for seasonal influenza vaccine which is expected to grow at a CAGR of XX% by 2022. Germany is expected to be third largest seasonal influenza vaccine market being followed by Japan by the end of the forecasted period.

 

Further, prudent analysis has been done on the competitor’s part, where three major players grab major share of the seasonal influenza vaccine market by revenue. Sanofi Pasteur, GlaxoSmithKline(GSK), Seqirus, AstraZeneca and Protein Sciences Corporation are the key influencers with their products in the seasonal influenza vaccine market. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, and VaxInnate are making novel technology based influenza vaccine which is likely to affect the market share during the forecast period.

 

Seven Major Markets(7MM) covered in the report are as follows:

1. United States
2. United Kingdom
3. France
4. Italy
5. Spain
6. Germany
7. Japan

Major and Promising Vaccines covered in the report are as follows:

1. Fluzone High–Dose
2. Fluzone Quadrivalent
3. Intradermal (ID) Trivalent
4. Vaxigrip
5. Fluarix Quadrivalent
6. Flulaval Quadrivalent
7. Fluenz Tetra
8. FluMist Quadrivalent
9. Flublok
10. VN–100
11. M–001
12. VAX–2012Q
13. TAK – 850

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projection using a suitable set of assumptions and methodologies. It provides essential insights into seasonal influenza vaccine sales forecasts for the top seven countries, comprising the US, the UK, France, Italy, Spain, Germany and Japan until 2022. It also covers vaccination patterns and geographic distribution and offers a clear view of the regulatory landscape.

Best Selling Market Reports : 

Seasonal Allergic Rhinitis Global Clinical Trials Review, H2, 2016

Global Avian Influenza Vaccines Consumption 2016

United States Influenza Vaccine Industry 2016 Market Research Report

About Aarkstore:

Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers.

 

%d bloggers like this: